Rate the Article: Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 150 | Views: 360 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Pharmaceutical Science | India | Volume 8 Issue 11, November 2019 | Rating: 6.3 / 10


Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism

Thrishankareddy P


Abstract: New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in peripheral venous thromboembolism. We assessed the effectiveness and safety along with side effects of rivaroxaban vs warfarin in patients experiencing venous thromboembolism (both deep vein thrombosis and pulmonary embolism)


Keywords: Venous thromboembolism, Warfarin, Rivaroxaban, Bleeding


Edition: Volume 8 Issue 11, November 2019,


Pages: 222 - 232



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top